Barclays Sees 22% Upside For AbbVie On Humira Opportunity
July 02, 2014 at 09:57 AM EDT
In a report published Tuesday, Barclays analyst Mark Purcell downgraded the sector view for U.S. Pharma majors from Positive to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.